SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-278320
Filing Date
2023-11-16
Accepted
2023-11-16 07:01:56
Documents
7
Period of Report
2023-11-16

Document Format Files

Seq Description Document Type Size
1 6-K d606065d6k.htm 6-K 10885
2 EX-99.1 d606065dex991.htm EX-99.1 62199
3 GRAPHIC g606065g0013g.jpg GRAPHIC 2985
4 GRAPHIC g606065g004g.jpg GRAPHIC 5755
5 GRAPHIC g606065g008g.jpg GRAPHIC 5802
6 GRAPHIC g606065sp009.jpg GRAPHIC 1600
7 GRAPHIC g606065sp10.jpg GRAPHIC 1753
  Complete submission text file 0001193125-23-278320.txt   99471
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38452 | Film No.: 231412390
SIC: 2834 Pharmaceutical Preparations